{"product_id":"go-healthy-go-probiotic-40-billion","title":"Go Healthy Go Probiotic 40 Billion","description":"\u003ch2\u003eGo Healthy Go Probiotic 40 Billion\u003c\/h2\u003e\r \u003ch3\u003eWhat is Go Probiotic 40 Billion?\u003c\/h3\u003e\r \u003cp\u003eGo Healthy Go Probiotic 40 Billion is a blend of four heat-stable and stomach acid resistant probiotic bacteria, which are live bacteria that provide health benefits. This probiotic blend is designed to restore and maintain a healthy balanced gut flora, which is essential to promote digestive health, protect against damage to the gastrointestinal system, maintain a strong immune system and promote general health and wellbeing.\u003c\/p\u003e\r \u003ch3\u003eWhy use Go Probiotic 40 Billion?\u003c\/h3\u003e\r \u003cp\u003eGut health is essential for overall health and wellness and this includes a balanced gut flora or microbiota, which is the complete collection of microorganisms that inhabit the gut  The gut microbiota should contain a balance between “good” bacteria, that provide many health benefits, and potentially pathogenic bacteria that cause harm to the gastrointestinal system and can trigger the gut immune system resulting in allergic and inflammatory reactions.  This balance can be disrupted by several factors including diet, lifestyle and medications, particularly non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics.  Go Probiotic 40 Billion contains a blend of four heat-stable and stomach acid resistant probiotic bacteria, designed to restore and maintain a healthy balanced gut flora, which is essential to promote digestive health, protect against damage to the gastrointestinal system, maintain a strong immune system and promote general health and wellbeing.\u003c\/p\u003e\r \u003ch3\u003eWhat are the Key Benefits of Go Probiotic 40 Billion?\u003c\/h3\u003e\r \u003cul\u003e\r     \u003cli\u003eProvides essential support during and after taking antibiotics\u003c\/li\u003e\r     \u003cli\u003eRestores and maintains good gut bacteria that is beneficial\u003c\/li\u003e\r     \u003cli\u003eMay help to treat IBS (Irritable Bowel Syndrome)\u003c\/li\u003e\r     \u003cli\u003eMay help inflammatory bowel disease \u0026amp; infectious or antibiotic related diarrhoea\u003c\/li\u003e\r     \u003cli\u003ePromotes moving food through the intestines more efficiently\u003c\/li\u003e\r     \u003cli\u003eMay help skin conditions such as eczema\u003c\/li\u003e\r     \u003cli\u003eMay work as a preventative for colds and allergies\u003c\/li\u003e\r     \u003cli\u003eMay support urinary and vaginal health\u003c\/li\u003e\r     \u003cli\u003eSuitable for long term use\u003c\/li\u003e\r     \u003cli\u003eCapsules are vegan and gluten and dairy free\u003c\/li\u003e\r     \u003cli\u003eSuitable for vegetarians and diary or gluten intolerances\u003c\/li\u003e\r \u003c\/ul\u003e\r \u003ch4\u003eWhat are probiotics?\u003c\/h4\u003e\r \u003cp\u003e\r Probiotics are defined as “live microorganisms which when administered in adequate amounts confer a health benefit on the host”\u003csup\u003e1.  \u003c\/sup\u003eTo put it more simply, we coexist with millions of live bacteria and other microorganisms in and on our body, the majority living in our gut, and these microorganisms are collectively known as the microbiota.  Probiotic refer to bacteria that live in the intestines and play an active health-promoting role\u003csup\u003e2, 3, 4.\u003c\/sup\u003e  The most well-known probiotics are Lactobacillus and Bifidobacteria species and they begin to develop in the gut of a new-born soon after birth\u003csup\u003e5.  \u003c\/sup\u003eThe balance between probiotic bacteria and potentially harmful bacteria, which together make up the microbiota of our gut, can be affected by several factors.  These include diet (high fat and sugar), excess alcohol, ageing, some medication (particularly antibiotics, oral contraceptives and NSAIDs), illness, stress, infection (enteric pathogens causing gastroenteritis), and lifestyle factors like smoking and lack of exercise.  An imbalance in the microbiota can cause health problems, due to digestive issues like lactose intolerance, or an impaired immune system predisposing to infection or to food allergies; while other are more serious such as Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS\u003csup\u003e)6, 7, 8.\u003c\/sup\u003e \u003c\/p\u003e\r \u003ch5\u003eHealth benefits of probiotics include:\u003c\/h5\u003e\r \u003cul\u003e\r     \u003cli\u003e\r     supporting the digestion of our food and absorption of vital nutrients\u003c\/li\u003e\r     \u003cli\u003e\r     protecting the gastric mucosa and maintaining the intestinal barrier function \u003c\/li\u003e\r     \u003cli\u003e\r     protecting against invasion with pathogenic microorganisms\u003c\/li\u003e\r     \u003cli\u003e\r     reducing inflammation due to their anti-inflammatory properties\u003c\/li\u003e\r     \u003cli\u003e\r     boosting the immune system, due to their immunomodulatory properties\u003c\/li\u003e\r \u003c\/ul\u003e\r \u003ch4\u003e\r Probiotics and the gut immune system\u003c\/h4\u003e\r \u003cp\u003e\r The gut wall contains 40-80% of our entire immune system and a finely tuned balance is maintained between the intestinal immune system and the gut microbiota, which have evolved together to support health and wellbeing.  The intestinal immune system protects against invasion with pathogenic microorganisms that cause disease, while at the same the immune cells maintain tolerance to many innocuous microorganisms and food substances in the gut.  An imbalance in the microbiota (dysbiosis) can impact significantly on health and disease outcomes.  The immune system can be triggered to initiate an inflammatory or allergic response, which can result in diseases of the gut, such as Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), or even predispose to systemic diseases like obesity and diabetes\u003csup\u003e9, 10, 11, 12.  \u003c\/sup\u003e\u003c\/p\u003e\r \u003ch4\u003e\r How do probiotics protect and restore gut health?\u003c\/h4\u003e\r \u003cp\u003e\r Probiotics help protect gut health and restore balance to a disturbed gut flora by several mechanisms.  Probiotic bacteria compete with pathogenic bacteria for binding sites on the gut surface, which are essential for pathogenic bacteria to be able to colonise in the gut.  Probiotics also produce acids that increase the acidic environment of the gut, in which many pathogens, such as enterohemorrhagic Escherichia coli, cannot survive; as well as producing bactericidal metabolites that kill some pathogenic bacteria, such as Salmonella, Staphylococcus, Clostridium and Listeria species.  Immune system modulation by probiotics activates cells of the gut immune system to fight bacteria.  The intestinal barrier function is critical for gut health, preventing inflammation and invasion with pathogenic microorganisms.  Probiotics protect the gut mucosa by stimulating mucus production, which also helps repair damage, restoring tight junctions between mucosal cells, and reducing production of inflammatory mediators\u003csup\u003e13, 14, 15.  \u003c\/sup\u003eProbiotics can help reduce lactose intolerance by digesting lactose, which can be triggered by an imbalance in gut microbiota\u003csup\u003e12. \u003c\/sup\u003e The final stage of digestion occurs in the colon, where non-digestible carbohydrates are fermented by the microbiota into various metabolites, mainly the short-chain fatty acids (SCFA) acetate, propionate and butyrate; also lactate, which is substrate for SCFA producing bacteria\u003csup\u003e16, 17.  \u003c\/sup\u003eIntroduction of a mixture of probiotic species was shown to restore balance to the microbiota by ensuring colonisation of SCFA producing bacteria, particularly butyrate, which has immunomodulating and anti-inflammatory properties\u003csup\u003e18.  \u003c\/sup\u003e\u003c\/p\u003e\r \u003ch4\u003e\r Probiotics and inflammatory bowel disease\u003c\/h4\u003e\r \u003cp\u003e\r Disturbances to a balanced gastrointestinal microbiota are involved in the pathogenesis of inflammatory bowel disease (IBD) like ulcerative colitis and Chron’s disease and studies indicate that an immune response to the intestinal microbiota may be responsible, along with damage to the intestinal barrier function of the gastric mucosa.  Probiotics have been found effective in treating IBD by preventing relapse and inducing remission in active IBD due to modulation of immune cells and by suppression of inflammatory cytokines and induction of anti-inflammatory cytokines \u003csup\u003e6, 19, 20.  \u003c\/sup\u003e\u003c\/p\u003e\r \u003ch4\u003e\r Probiotics and antibiotics\u003c\/h4\u003e\r \u003cp\u003e\r Antibiotics can cause a major alteration in the gut microbiota, by reducing the numbers of probiotic bacteria, leaving harmful microorganisms like Clostridium difficile to take over.  This results in antibiotic associated diarrhoea (AAD), which has become a major complication of antibiotic use, and has also increased risk of antibiotic resistance within the individual microbiota.  Several studies have demonstrated that probiotics are a safe and effective treatment to help restore balance to gut flora when taking antibiotics\u003csup\u003e3, 21, 22;\u003c\/sup\u003e and may be used for prophylaxis in preventing AAD for high risk patients in both hospital and outpatient settings, particularly for those who have previously had serious episodes of AAD\u003csup\u003e23,24,25,26.  \u003c\/sup\u003e\u003c\/p\u003e\r \u003ch4\u003e\r Probiotics and NSAID-induced enteropathy\u003c\/h4\u003e\r \u003cp\u003e\r Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain and inflammation but in many cases can cause damage to the gastric mucosa resulting in a range of gastrointestinal symptoms known as NSAID-induced enteropathy.  These include abdominal pain, abdominal distension, nausea, indigestion, constipation, and more seriously intestinal bleeding and ulceration.  It is thought that NSAID-induced enteropathy is caused by dysbiosis or an imbalance between in the gut microbiota\u003csup\u003e27.\u003c\/sup\u003e  Animal and clinical studies have demonstrated that probiotics are effective in protecting against NSAID-induced enteropathy\u003csup\u003e28, 29.\u003c\/sup\u003e\u003c\/p\u003e\r \u003ch4\u003e\r What is an immunomodulator?\u003c\/h4\u003e\r \u003cp\u003e\r The immune system is the body’s natural defence against invasion by environmental pathogens, like bacteria, viruses and parasites, and is a complex process that involves many cell types that produce an array of chemical mediators like cytokines and interferon; also antibodies.  The various components of the immune system work together with the aim of recognising foreign invaders from self and destroying the invader.  An immunomodulator is a substance (chemical or herbal) that affects the way the immune system works either by stimulating it (immunostimulant) or suppressing it (Immunosuppressant).\r \u003c\/p\u003e\r \u003ch4\u003e\r What is CFU?\u003c\/h4\u003e\r \u003cp\u003e\r A colony forming unit (CFU) is an estimate of the number of viable bacterial cells that are alive and can multiply to form colonies under controlled conditions.  The number of CFUs is used to quantify how many living bacteria exist in a biological sample.\u003c\/p\u003e\r \u003ch3\u003eWhat are the Benefits of the Howaru Restore® Blend?\u003c\/h3\u003e\r \u003cp\u003eHOWARU Restore in Go Probiotic 40 Billion is a mixture of four strains of probiotics that have been tested for their safety and efficacy in providing health benefits, when used as probiotic supplements.  These are Lactobacillus acidophilus NCFM (ATCC SD5221), Lactobacillus paracasei Lpc-37 (ATCC SD5240), Bifidobacterium animalis subsp. lactis Bl-04 (ATCC SD5219) and B. animalis subsp. lactis Bi-07 (ATCC SD5220), blended in a 1:1:1:1 ratio\u003csup\u003e30.  \u003c\/sup\u003eLactobacillus acidophillus, Lactobacillus paracasei and Bifidobacterium lactis (strains BI-07 and Bl-04) are non-spore forming, species of probiotic bacteria that produce lactic acid but through different metabolic pathways.  Lactobacilli are more prevalent in the upper intestines, whereas bifidobacterial are found mainly in the colon.  Bifidobacterium lactis is found in faeces of infants indicating that it is present early in life and therefore, makes up an important part of the early microbiota.  These strains have been widely used in probiotic supplements and are considered safe for consumption\u003csup\u003e30.\u003c\/sup\u003e  A clinical study demonstrated that use of HOWARU Restore given to hospital patients receiving antibiotic treatment, reduced the incidence of antibiotic associated diarrhoea (AAD) and Clostridium difficile associated diarrhoea (CDAD); also the severity of gastrointestinal symptoms\u003csup\u003e31.\u003c\/sup\u003e\u003c\/p\u003e\r \u003ch3\u003eIs Go Probiotic 40 Billion safe to take during Pregnancy?\u003c\/h3\u003e\r \u003cp\u003eGo Probiotic 40 Billion is safe to take during pregnancy and breastfeeding.\u003c\/p\u003e\r \u003ch3\u003eWhat are the Ingredients of Go Probiotic 40 Billion?\u003c\/h3\u003e\r \u003cp\u003eEach capsule of Go Probiotic 40 Billion contains the following probiotic bacteria.\u003c\/p\u003e\r \u003ch4\u003e\r HOWARU Restore providing 40 billion CFU (Colony Forming Units) comprising:\u003c\/h4\u003e\r \u003cul\u003e\r     \u003cli\u003e\r     Lactobacillus acidophillus ATCC\t10 billion cells CFU,\u003c\/li\u003e\r     \u003cli\u003e\r     Lactobacillus paracasei\t\t10 billion cells CFU\u003c\/li\u003e\r     \u003cli\u003e\r     Bifidobacterium lactis (strain Bi-07)\t10 billion cells CFU\u003c\/li\u003e\r     \u003cli\u003e\r     Bifidobacterium lactis (strain Bl-04)\t10 billion cells CFU\u003c\/li\u003e\r \u003c\/ul\u003e\r \u003ch3\u003eWhat are the Contraindications\/Interactions of Go Probiotic 40 Billion?\u003c\/h3\u003e\r \u003cp\u003e\r You should always check the ingredients for known allergies and to ensure you do not have any allergies or sensitivities to these ingredients.  Stop using if you develop any irritation or allergy while taking Go Probiotic 40 Billion.  Always read the label and use as directed or seek advice from your healthcare professional.\u003c\/p\u003e\r \u003ch4\u003e\r Caution\u003c\/h4\u003e\r \u003cp\u003e\r Go Probiotic 40 Billion should be used with caution if immunocompromised. \u003c\/p\u003e\r \u003ch4\u003e\r Side effects\u003c\/h4\u003e\r \u003cp\u003e\r Probiotics are considered safe and any side effects are usually minimal but can include gas and bloating. \u003c\/p\u003e\r \u003ch4\u003e\u003c\/h4\u003e\r \u003ch3\u003eWhat is the Dosage Recommendation for Go Probiotic 40 Billion?\u003c\/h3\u003e\r \u003ch5\u003eAdults (Maintenance):\u003c\/h5\u003e\r \u003cp\u003eTake 1 VegeCapsule daily with food.\u003c\/p\u003e\r \u003ch5\u003eAdults:\u003c\/h5\u003e\r \u003cp\u003eMay be increased up to 2 VegeCapsules daily\u003c\/p\u003e\r \u003ch5\u003eChildren (12 years +): \u003c\/h5\u003e\r \u003cp\u003eTake 1 VegeCapsule daily\u003c\/p\u003e\r \u003ch5\u003eChildren (3 years +): \u003c\/h5\u003e\r \u003cp\u003eEmpty 1 VegeCapsule and mix into food daily\u003c\/p\u003e\r \u003ch5\u003eInfants (6 mths +):\u003c\/h5\u003e\r \u003cp\u003eEmpty 1 VegeCapsule and mix into formula or milk daily\u003c\/p\u003e\r \u003ch3\u003eShould Go Probiotic 40 Billion be Refrigerated?\u003c\/h3\u003e\r \u003cp\u003eGo Probiotic 40 Billion is clinically proven to be shelf stable up to 25ºC. To maintain optimal effectiveness it is recommended that you refrigerate all live probiotics after opening and using them before the expiry date on tha bottle.\u003c\/p\u003e\r \u003ch3\u003eProduct Sizes\u003c\/h3\u003e\r \u003cp\u003e30 \u0026amp; 60 VegeCapsules\u003c\/p\u003e\r \u003ch3\u003eReferences\u003c\/h3\u003e\r \u003ch5\u003eThe following references provide scientific support for the use of this product:\u003c\/h5\u003e\r \u003col\u003e\r     \u003cli\u003eFAO\/WHO. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO\/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food; Ontario, Canada. April 30 and May 1, 2002.\u003c\/li\u003e\r     \u003cli\u003eBehnsen J, Deriu E, Sassone-Corsi M, Raffatellu M. Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med. 2013;3:a010074.\u003c\/li\u003e\r     \u003cli\u003eClemente JC, Ursell LK, Parfrey LW, Knight R.  The Impact of the Gut Microbiota on Human Health: An Integrative View.  Cell 2012, 148 issue 6, 1258-70\u003c\/li\u003e\r     \u003cli\u003eO’Hara AM, Shanahan F.  The gut flora as a forgotten organ. EMBO Reports 2006; 7(7) 688-693.\u003c\/li\u003e\r     \u003cli\u003eServin AL.  Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.  FEMS Microbiology Reviews 28 (2004) 405–440\u003c\/li\u003e\r     \u003cli\u003eOrel R, Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol. 2014 Sep 7;20(33):11505-24\u003c\/li\u003e\r     \u003cli\u003eCresci GA, Bawden E.  Gut Microbiome: What We Do and Don't Know. Nutr Clin Pract 2015 Dec;30(6):734-46.   \u003c\/li\u003e\r     \u003cli\u003eHungin APS, Mulligan C, Pot B, Whorwell P, Agreus L, Fracasso P, et al. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence based international guide.  Aliment Pharmacol Ther 2013 Oct; 38(8): 864–886.\u003c\/li\u003e\r     \u003cli\u003eCader MZ, Kaser A.  Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 2013 Nov;62(11):1653-64. \u003c\/li\u003e\r     \u003cli\u003eLei YM, Nair L, Alegre ML. The interplay between the intestinal microbiota and the immune system. Clin Res Hepatol Gastroenterol 2015 Feb;39(1):9-19. \u003c\/li\u003e\r     \u003cli\u003eBischoff C. 'Gut health': a new objective in medicine? BMC Medicine2011; 9:24\u003c\/li\u003e\r     \u003cli\u003eOak SJ, Jha R. The effects of probiotics in lactose intolerance: A systematic review. Crit Rev Food Sci Nutr 2018 Feb 9:1-9. How do probiotics work\u003c\/li\u003e\r     \u003cli\u003eMathipa MG, Thantsha MS.  Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.  Gut Pathog (2017) 9:28\u003c\/li\u003e\r     \u003cli\u003eVanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis. 2008;14:1585–1596.\u003c\/li\u003e\r     \u003cli\u003e Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther.2006 Apr;4(2):261-40. \u003c\/li\u003e\r     \u003cli\u003eden Besten G, van Eunen K, Groen A. K, Venema K, Reijngoud D-J, Bakker BM. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54 2325–2340. 10. \u003c\/li\u003e\r     \u003cli\u003eRivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulatioan in the Human Gut.  Front Microbiol 2016; 7: 979.\u003c\/li\u003e\r     \u003cli\u003eMoens F, Van den Abbeele P, Basit AW, Dodoo C, Chatterjee R, Smithd B, Gaisford S.  A four-strain probiotic exerts positive immunomodulatory effects by enhancing colonic butyrate production in vitro. Int J of Pharm 2018; 555, 1–10. \u003c\/li\u003e\r     \u003cli\u003eDerwa Y, Gracie DJ, Hamlin PJ, Ford AC.  Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 2017 Aug;46(4):389-400. \u003c\/li\u003e\r     \u003cli\u003eGanji-Arjenaki M, Rafieian-Kopaei M.  Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol 2018 \u003c\/li\u003e\r     \u003cli\u003eCai J, Zhao C, Du Y, Zhang Y, Zhao M, Zhao Q.  Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: Systematic review with network meta-analysis. United European Gastroenterol J 2018 Mar;6(2):169-180.  \u003c\/li\u003e\r     \u003cli\u003eGoldenberg JZ, Yap C, Lytvyn L, Lo CKF, Beardsley J, Mertz D, Johnston BC.  Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.  Cochrane Database Syst Rev. 2017 Dec 19;12:CD006095.  \u003c\/li\u003e\r     \u003cli\u003eIssa I, Moucari R.  Probiotics for antibiotic-associated diarrhea: Do we have a verdict? World J Gastroenterol.2014 Dec 21;20(47):17788-95.\u003c\/li\u003e\r     \u003cli\u003eBlaabjerg S, Artzi DM, Rune Aabenhus R. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients—A Systematic Review and Meta-Analysis.  Antibiotics 2017, 6, 21;\u003c\/li\u003e\r     \u003cli\u003eHempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, et al.  Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea. A Systematic Review and Meta-analysis.  JAMA. 2012 May 9;307(18):1959-69. \u003c\/li\u003e\r     \u003cli\u003eJohnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012;157:878–888.  \u003c\/li\u003e\r     \u003cli\u003eRogers MAM, Aronoff DM.  The influence of non-steroidal anti-inflammatory drugs on the gut microbiome.  Clin Microbiol Infect 2016; 22: 178.e1–178.e9\u003c\/li\u003e\r     \u003cli\u003eSyer SD, Blackler RW, Martin R, de Palma G, Rossi L, et al.  NSAID enteropathy and bacteria: a complicated relationship. J Gastroenterol.2015 Apr;50(4):387-93.\u003c\/li\u003e\r     \u003cli\u003eMontalto M, Gallo A, Gasbarrini A, Landolfi R.  NSAID enteropathy: could probiotics prevent it? J Gastroenterol.2013 Jun;48(6):689-97. \u003c\/li\u003e\r     \u003cli\u003eMorovica W, Roper JM, Smith AB, Mukerji P, Stahla B, Rae JC, Ouwehand AC.  Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity.  Food and Chemical Toxicology 110 (2017) 316–324\u003c\/li\u003e\r     \u003cli\u003eOuwehand AC, DongLian C, Weijian X, Stewart M, Ni J, Stewart T, Miller LE.  Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine.2014 Jan 16;32(4):458-63. \u003c\/li\u003e\r \u003c\/ol\u003e\r \u003cp\u003e \u003c\/p\u003e","brand":"Go Healthy","offers":[{"title":"30caps","offer_id":31177661317165,"sku":"00287-30caps","price":33.0,"currency_code":"NZD","in_stock":true},{"title":"60caps","offer_id":31177661349933,"sku":"00287-60caps","price":52.13,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0268\/9954\/6157\/products\/1120207.jpg?v=1573461064","url":"https:\/\/nz-nutristrong.myshopify.com\/products\/go-healthy-go-probiotic-40-billion","provider":"NZ NutriStrong","version":"1.0","type":"link"}